CLINICAL_TRIALS
trial_result
· 2015-05-05
Clinical Trial Update: Pharmacological Postconditioning to Reduce Infarct Size Following Primary PCI [Phase 4]
Summary
This update reports the completion of a Phase 4 clinical trial evaluating pharmacological postconditioning to reduce infarct size after primary PCI in myocardia…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Rigshospitalet, Denmark | Conditions: Myocardial Infarction | Phase 4 | Status: COMPLETED